Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia

Experimental Hematology

Volumn 41, Issue 10, 2013, Pages 837-847

  Sloma, Ivan ^a,b   Beer, Philip A ^a   Saw, Kyi Min ^a   Chan, Matthew ^a   Leung, Donna ^a   Raghuram, Kamini ^a   Brimacombe, Cedric ^a   Johnston, Bobby ^a   Lambie, Karen ^a   Forrest, Donna ^c   Jiang, Xiaoyan ^a   Eaves, Connie J ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b HÔPITAL PAUL BROUSSE   (France)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; STEEL FACTOR;

ANIMAL EXPERIMENT; BCR ABL1 GENE; BURST FORMING UNIT E; CANCER STEM CELL; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; FIBROBLAST; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENOTYPE; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

MUS;

EID: 84885732608     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2013.07.001     Document Type: Article

References (24)

1. Sloma I., Jiang X., Eaves A.C., Eaves C.J. Insights into the stem cells of chronic myeloid leukemia. Leukemia 2010, 24:1823-1833.
2. Chomel J.C., Bonnet M.L., Sorel N., et al. Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease. Blood 2011, 118:3657-3660.
3. Jiang X., Zhao Y., Smith C., et al. Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies. Leukemia 2007, 21:926-935.
4. Chu S., McDonald T., Lin A., et al. Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment. Blood 2011, 118:5565-5572.
5. Mahon F.X., Réa D., Guilhot J., et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol 2010, 11:1029-1035.
6. Holyoake T.L., Jiang X., Drummond M.W., Eaves A.C., Eaves C.J. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia 2002, 16:549-558.
7. Järås M., Johnels P., Hansen N., et al. Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein. Proc Natl Acad Sci U S A 2010, 107:16280-16285.
8. Doulatov S., Notta F., Laurenti E., Dick J.E. Hematopoiesis: a human perspective. Cell Stem Cell 2012, 10:120-136.
9. Benveniste P., Frelin C., Janmohamed S., et al. Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential. Cell Stem Cell 2010, 6:48-58.
10. Jiang X., Saw K.M., Eaves A., Eaves C. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells. J Natl Cancer Inst 2007, 99:680-693.
11. Sloma I., Imren S., Beer P.A., et al. Exvivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene. Leukemia 2013, 27:159-169.
12. Petzer A.L., Eaves C.J., Lansdorp P.M., Ponchio L., Barnett M.J., Eaves A.C. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 1996, 88:2162-2171.
13. Sutherland H.J., Hogge D.E., Cook D., Eaves C.J. Alternative mechanisms with and without steel factor support primitive human hematopoiesis. Blood 1993, 81:1465-1470.
14. Fraser C., Eaves C.J., Kalousek D.K. Fluorodeoxyuridine synchronization of hemopoietic colonies. Cancer Genet Cytogenet 1987, 24:1-6.
15. Glimm H., Eisterer W., Lee K., et al. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J Clin Invest 2001, 107:199-206.
16. Cheung A.M., Leung D., Rostamirad S., et al. Distinct but phenotypically heterogeneous human cell populations produce rapid recovery of platelets and neutrophils after transplantation. Blood 2012, 119:3431-3439.
17. Wang J.C., Doedens M., Dick J.E. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative invivo SCID-repopulating cell assay. Blood 1997, 89:3919-3924.
18. Martin P.J., Najfeld V., Hansen J.A., Penfold G.K., Jacobson R.J., Fialkow P.J. Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature 1980, 287:49-50.
19. Eisterer W., Jiang X., Christ O., et al. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease. Leukemia 2005, 19:435-441.
20. Savona M., Talpaz M. Getting to the stem of chronic myeloid leukaemia. Nat Rev Cancer 2008, 8:341-350.
21. Marin D., Ibrahim A.R., Lucas C., et al. Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. J Clin Oncol 2012, 30:232-238.
22. Hanfstein B., Müller M.C., Hehlmann R., et al. Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia 2012, 26:2096-2102.
23. Hogge D.E., Lansdorp P.M., Reid D., Gerhard B., Eaves C.J. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood 1996, 88:3765-3773.
24. Notta F., Doulatov S., Laurenti E., Poeppl A., Jurisica I., Dick J.E. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011, 333:218-221.